1977
DOI: 10.1016/0005-2760(77)90140-0
|View full text |Cite
|
Sign up to set email alerts
|

Antibodies to lipoprotein lipase application to perfused heart

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

1984
1984
2007
2007

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(4 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…Immunotitration experiments Antibodies to purified rat heart LPL were isolated as described by Schotz et al (1977). Control IgG and the anti-LPL IgG fractions were dialysed before use against 5 mM-sodium phosphate/15 mM-NaCl, pH 7.5, and then centrifuged to remove any insoluble material.…”
Section: Triacylglycerol Hydrolase Assaysmentioning
confidence: 99%
See 1 more Smart Citation
“…Immunotitration experiments Antibodies to purified rat heart LPL were isolated as described by Schotz et al (1977). Control IgG and the anti-LPL IgG fractions were dialysed before use against 5 mM-sodium phosphate/15 mM-NaCl, pH 7.5, and then centrifuged to remove any insoluble material.…”
Section: Triacylglycerol Hydrolase Assaysmentioning
confidence: 99%
“…LPL (EC 3.1.1.34) has been located at the capillary endothelium of the heart by immunocytochemical techniques (Pedersen et al, 1983). Displacement of this endothelium-bound enzyme by perfusion with heparin (Borensztajn & Robinson, 1970) or inhibition of enzyme activity by antibodies to LPL (Schotz et al, 1977) results in a marked decrease in the ability of the heart to metabolize chylomicrons. Therefore LPL at the capillary endothelium of the heart has a functional role in the degradation of the TG component of circulating lipoproteins.…”
Section: Introductionmentioning
confidence: 99%
“…The endothelium-bound enzyme (Fig. 1) is often referred to as " functional LPL" since displacement of the enzyme by perfusion with heparin [4,15] or inhibition of enzyme activity by antibodies to LPL [16] resulted in marked reduction in the ability of perfused hearts, for example, to degrade lipoproteins.…”
Section: Introductionmentioning
confidence: 99%
“…Since heparin does not rapidly penetrate the vascular endothelium, they suggested that the heparin-releasable LPL represented the enzyme at the endothelium. This has been designated as the "functional LPL", since it is this fraction that can act on lipoproteins in blood (45). It was concluded that modulation of LPL in heart entailed a shift of the enzyme to or from the endothelium, in contrast to adipose tissue, where regulation was exerted on the amount of the enzyme (28).…”
mentioning
confidence: 98%